Sundaram: Weight-Loss Drugs, Focus on 'Fresh' Impacting GIS

General Mills (GIS) shares are lower following mixed earnings. CFRA's Arun Sundaram joins Morning Movers to discuss the consumer staple's difficult year and pivot within its business model to "spur volume growth." Arun adds that it is impacting all packaged foods companies, while indicating that there will likely be more promotions and changes to pack sizes to "get things going again." However, he adds that trends with GLP-1 drugs like Ozempic and consumer focus on "fresh" products could be denting sales.

Morning Movers

25 Jun 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor